Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression

AIDS Research and Human Retroviruses

Volumn 17, Issue 14, 2001, Pages 1333-1344

  Demarest, James F ^a   Jack, Noreen ^b   Cleghorn, Farley R ^c   Greenberg, Michael L ^a   Hoffman, Trevor L ^d   Ottinger, Janet S ^a   Fantry, Lori ^c   Edwards, Jeffrey ^b   O’Brien, Thomas R ^e   Cao, Kai ^f   Mahabir, Bisram ^g   Blattner, William A ^c   Bartholomew, Courtenay ^b   Weinhold, Kent J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

^g Trinidad and Tobago Ministry of Education   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOLOGIC FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BIODIVERSITY; CELL ADHESION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; PHENOTYPE; PRIORITY JOURNAL; SEROCONVERSION; VIROLOGY; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS ISOLATION;

ACUTE DISEASE; ADULT; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LYMPHOCYTE SUBSETS; MALE; MOLECULAR SEQUENCE DATA; RECEPTORS, HIV; RNA, VIRAL; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD; VIRUS REPLICATION;

EID: 0034754889     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220152596597     Document Type: Article

References (69)

1. New concepts in the immunopathogenesis of HIV infection
2. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men
3. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study
4. Course of HIV-1 infection in a cohort of homosexual and bisexual men: An 11 year follow up study
5. Effect of age at seroconversion on the natural AIDS incubation distribution
6. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection
7. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection
8. The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course?
9. The characterization of non-progressors: Long-term HIV-1 infection with stable CD4+ T-cell levels
10. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection
11. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term non-progressors
12. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
13. Hiv-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons
14. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV type 1 infection
15. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection
16. AIDS two months after primary human immunodeficiency virus infection
17. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV
18. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia
19. Clinical and epidemiologic features of primary HIV infection
20. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
21. Prognosis in HIV-1 infection predicted by the quantity of virus plasma
22. Plasma viral load and CD41 lymphocytes as prognostic markers of HIV-1 infection
23. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study
24. DAIDS virology manual for the HIV laboratory
25. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
26. Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry
27. Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults
28. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to determinants on normal lymphocytes and expressed by infected cells serves as targets for immune attack
29. Oligoclonal CD8 lymphocytes from person with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication
30. Revised guidelines for the performance of CD41 T cell determinations in persons with human immunodeficiency virus (HIV) infection
31. A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes
32. Population diversity of B-locus alleles observed by high-resolution DNA typing
33. HLA class I typing by sequence-specific oligonucleotide probes after genomic DNA amplification
34. Characterization of LMP polymorphism in homozygous typing cells and a random population
35. Predictors of rapid progression to AIDS in HIV-1 seroconverters
36. Antibody responses to HIV-1 envelope and Gag epitopes in HIV-1 serocon-verters with rapid versus slow disease progression
37. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
38. V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability
39. Phenotype-associated sequence variation in the third variable domain of the human immu-nodeficiency virus type 1 gp120 molecule
40. Coreceptor use by primate lentiviruses
41. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
42. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins
43. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus
44. Rapid progression of HIV-1 infection to AIDS
45. Alcoholism and rapid progression to AIDS after seroconversion
46. Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man
47. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection-evidence for highly susceptible human hosts
48. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
49. CXCR4 utilization is sufficient to trigger CD41 T cell depletion in HIV-1-infected human lymphoid tissue
50. Virus-specific CD8+ cytotoxic T lymphocyte activity associated with control viremia in primary human immunodeficiency virus type 1 infection
51. Temporal association of cellular immune response with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
52. HIV-specific cellular and humoral immune responses in primary HIV infection
53. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection
54. Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes
55. AIDS virus-specific cytotoxic T lymphocytes in lung disorders
56. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection
57. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
58. Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS
59. Divergent patterns of progression to AIDS after infection from the same source: Human immunodeficiency virus type 1 evolution and antiviral responses
60. Complement-activating antibodies in sera from infected individuals and vaccinated volunteers that target human immunodeficiency virus type 1 to complement receptor type 1 (CR1, CD35)
61. Lack of infection in HIV-exposed individuals is associated with a strong CD8(1) cell noncytotoxic anti-HIV response
62. The immunopathogenesis of human immunodeficiency virus infection
63. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection
64. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection
65. Syncytium-inducing (SI) phenotype suppression at sero-conversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population
66. Cytotoxic T lymphocytes in HIV-1 infection: A killing paradox?
67. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
68. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA